RH.NYSERh

Form 4: RH Director Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


📋All filings for Rh

RH Director Mark S. Demilio reported selling 900 shares of common stock across two transactions in late December 2025.

Summary

  • Mark S. Demilio, a Director of RH, reported the sale of 900 shares of RH common stock.
  • On December 30, 2025, 500 shares were sold at a price of $184 per share.
  • On December 31, 2025, an additional 400 shares were sold at a weighted average price of $180.1692 per share.
  • These transactions were made pursuant to a Rule 10b5-1 trading plan, which was indicated by checking the relevant box.
  • Following these transactions, Mr. Demilio beneficially owns 23,716 shares indirectly through The Mark S. Demilio Revocable Trust, 19,425 shares indirectly through The Theresa E. Demilio 2012 Family Trust, and 12,717 shares directly.

Sentiment

Score: 5

Explanation: The filing is a neutral, factual report of insider transactions. While director sales can sometimes be viewed negatively, the disclosure of a 10b5-1 plan mitigates some potential negative interpretation, indicating a pre-planned transaction rather than a reaction to immediate events.

Positives

  • The transactions were executed pursuant to a Rule 10b5-1 trading plan, which suggests the sales were pre-scheduled and not based on immediate, non-public information.

Negatives

  • A director selling shares, even under a pre-arranged plan, could be perceived negatively by some investors, potentially signaling a desire to diversify holdings or a view on valuation.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • The shares sold on December 30, 2025, and December 31, 2025, were held by The Mark S. Demilio Revocable Trust.
  • An additional 19,425 shares are held by The Theresa E. Demilio 2012 Family Trust, of which Mr. Demilio is a beneficiary and Co-Trustee.

Stakeholder Impact

  • Shareholders: May interpret the director's sale as a signal, potentially influencing their perception of the company's short-term prospects or valuation, despite the 10b5-1 plan.

Key Dates

DateDescription
12/30/2025Transaction date for the sale of 500 shares of Common Stock.
12/31/2025Transaction date for the sale of 400 shares of Common Stock.
01/02/2026Date the Form 4 was signed by Jill Falor, Attorney-in-Fact for Mark S. Demilio.

Keywords

RH, Mark S. Demilio, Insider Trading, Form 4, Stock Sale, Director, Beneficial Ownership, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.